← Back to Clinical Trials
Recruiting NCT06754995

NCT06754995 Diagnostic Feasibility of 100 Hz Tetanic Stimulation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06754995
Status Recruiting
Phase
Sponsor University of Debrecen
Condition Polyneuropathies
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2025-01-06
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2025-01-06 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to investigate the applicability of 100 Hz tetanic stimulation with an electromyography device in the exclusion of postoperative residual neuromuscular block. The aim is to determine whether fatigue develops with 100 Hz tetanic stimulation in anaesthetized, non-relaxed patients with normal or abnormal baseline electroneurographic (ENG) findings.

Eligibility Criteria

Inclusion Criteria: * ASA 1-3; * BMI 18.5-25 (normal body weight); * patient is in supine position with one arm accessible. Exclusion Criteria: * diseases with impaired neuromuscular function (myopathies, severe liver and kidney failure); * drugs affecting neuromuscular function (magnesium, aminoglycosides); * pregnancy (pregnancy tests are carried out in women of childbearing age to rule out pregnancy); * breast-feeding; * acute surgery

Contact & Investigator

Central Contact

Adrienn Pongrácz, MD PhD

✉ pongadri@gmail.com

📞 +36302390132

Principal Investigator

Béla Fülesdi, MD PhD DSci

STUDY DIRECTOR

University of Debrecen

Frequently Asked Questions

Who can join the NCT06754995 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Polyneuropathies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06754995 currently recruiting?

Yes, NCT06754995 is actively recruiting participants. Contact the research team at pongadri@gmail.com for enrollment information.

Where is the NCT06754995 trial being conducted?

This trial is being conducted at Debrecen, Hungary, Debrecen, Hungary.

Who is sponsoring the NCT06754995 clinical trial?

NCT06754995 is sponsored by University of Debrecen. The principal investigator is Béla Fülesdi, MD PhD DSci at University of Debrecen. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology